| Literature DB >> 19402898 |
Nathan Zoanetti1, Patrick Griffin, Mark Beaves, Euan M Wallace.
Abstract
BACKGROUND: It is widely recognised that deficiencies in fetal surveillance practice continue to contribute significantly to the burden of adverse outcomes. This has prompted the development of evidence-based clinical practice guidelines by the Royal Australian and New Zealand College of Obstetricians and Gynaecologists and an associated Fetal Surveillance Education Program to deliver the associated learning. This article describes initial steps in the validation of a corresponding multiple-choice assessment of the relevant educational outcomes through a combination of item response modelling and expert judgement.Entities:
Mesh:
Year: 2009 PMID: 19402898 PMCID: PMC2685791 DOI: 10.1186/1472-6920-9-20
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Hypothesised competency levels for the FSEP assessment variable
Figure 1Relationship between items, errors and the latent variable.
Figure 2Schema of the construct validation methodology.
FSEP assessment classical and Rasch item statistics (n = 877)
| 1 | 1002 | 0.88 | 0.33 | 0.25 | 0.30 | 0.79 | 5.59 | -0.18 | 88.58 | 0.25 | 2.10 | -0.15 | 3.26 | -0.06 | 0.47 | -1.22 | 1.00 |
| 2 | 1006 | 0.87 | 0.34 | 0.30 | 0.34 | 0.79 | 2.80 | -0.18 | 3.26 | -0.16 | 88.11 | 0.30 | 5.59 | -0.16 | 0.23 | -1.19 | 0.99 |
| 3 | 1007 | 0.57 | 0.50 | 0.36 | 0.29 | 0.79 | 19.11 | -0.25 | 6.29 | -0.11 | 58.04 | 0.36 | 16.55 | -0.14 | 0.00 | 0.55 | 0.99 |
| 4 | 1008 | 0.89 | 0.31 | 0.10 | 0.19 | 0.80 | 1.40 | -0.03 | 90.44 | 0.10 | 7.46 | -0.08 | 0.47 | -0.09 | 0.23 | -1.46 | 1.06 |
| 5 | 1009 | 0.72 | 0.45 | 0.34 | 0.30 | 0.79 | 15.38 | -0.31 | 1.63 | -0.06 | 72.73 | 0.34 | 10.26 | -0.10 | 0.00 | -0.2 | 0.98 |
| 6 | 1003 | 0.85 | 0.35 | 0.37 | 0.39 | 0.79 | 86.48 | 0.37 | 12.12 | -0.29 | 1.17 | -0.23 | 0.23 | -0.12 | 0.00 | -1.1 | 0.95 |
| 7 | 1010 | 0.6 | 0.49 | 0.37 | 0.30 | 0.79 | 61.07 | 0.37 | 11.19 | -0.28 | 25.17 | -0.17 | 2.56 | -0.10 | 0.00 | 0.44 | 0.98 |
| 8 | 1011 | 0.68 | 0.47 | 0.41 | 0.36 | 0.79 | 1.40 | -0.09 | 68.76 | 0.41 | 5.83 | -0.29 | 24.01 | -0.26 | 0.00 | 0.29 | 0.98 |
| 9 | 1012 | 0.49 | 0.50 | 0.37 | 0.29 | 0.79 | 34.03 | -0.21 | 10.96 | -0.13 | 5.13 | -0.20 | 49.88 | 0.37 | 0.00 | 1.06 | 1.01 |
| 10 | 1013 | 0.56 | 0.50 | 0.36 | 0.29 | 0.79 | 0.70 | -0.04 | 39.39 | -0.33 | 3.50 | -0.06 | 56.18 | 0.36 | 0.23 | 0.56 | 0.98 |
| 11 | 1014 | 0.68 | 0.47 | 0.25 | 0.21 | 0.80 | 3.73 | -0.05 | 68.30 | 0.25 | 1.63 | -0.06 | 26.11 | -0.21 | 0.23 | 0.31 | 1.06 |
| 12 | 1015 | 0.78 | 0.41 | 0.21 | 0.21 | 0.80 | 79.25 | 0.21 | 19.35 | -0.20 | 0.93 | -0.06 | 0.00 | NA | 0.47 | -0.55 | 1.03 |
| 13 | 1016 | 0.71 | 0.45 | 0.39 | 0.35 | 0.79 | 5.59 | -0.20 | 19.11 | -0.24 | 71.79 | 0.39 | 3.26 | -0.19 | 0.23 | -0.16 | 0.94 |
| 14 | 1017 | 0.58 | 0.49 | 0.26 | 0.21 | 0.80 | 31.93 | -0.11 | 5.83 | -0.14 | 58.97 | 0.26 | 3.26 | -0.25 | 0.00 | 0.55 | 1.02 |
| 15 | 1018 | 0.47 | 0.50 | 0.10 | 0.05 | 0.80 | 20.05 | 0.02 | 4.90 | -0.17 | 27.27 | -0.03 | 47.32 | 0.10 | 0.47 | 1.18 | 1.12 |
| 16 | 1019 | 0.87 | 0.34 | 0.33 | 0.36 | 0.79 | 6.99 | -0.24 | 2.10 | -0.10 | 1.63 | -0.09 | 87.65 | 0.33 | 1.63 | -1.16 | 0.98 |
| 17 | 1020 | 0.9 | 0.30 | 0.21 | 0.29 | 0.79 | 2.56 | -0.14 | 91.38 | 0.21 | 2.80 | -0.06 | 2.33 | -0.12 | 0.93 | -1.52 | 1.02 |
| 18 | 1021 | 0.7 | 0.46 | 0.43 | 0.39 | 0.79 | 10.72 | -0.18 | 2.80 | -0.28 | 15.62 | -0.24 | 70.63 | 0.43 | 0.23 | -0.05 | 0.95 |
| 19 | 1022 | 0.76 | 0.43 | 0.42 | 0.40 | 0.79 | 0.93 | -0.10 | 77.39 | 0.42 | 19.35 | -0.31 | 2.33 | -0.29 | 0.00 | -0.4 | 0.96 |
| 20 | 1023 | 0.91 | 0.28 | 0.26 | 0.35 | 0.79 | 1.86 | -0.16 | 92.54 | 0.26 | 3.03 | -0.14 | 2.56 | -0.15 | 0.00 | -1.91 | 0.98 |
| 21 | 1024 | 0.87 | 0.33 | 0.21 | 0.26 | 0.79 | 4.90 | -0.06 | 88.34 | 0.21 | 3.73 | -0.07 | 2.10 | -0.16 | 0.93 | -1.22 | 1.01 |
| 22 | 1025 | 0.75 | 0.43 | 0.32 | 0.30 | 0.79 | 75.99 | 0.32 | 5.13 | -0.06 | 9.56 | -0.25 | 8.16 | -0.11 | 1.17 | -0.22 | 0.99 |
| 23 | 1026 | 0.78 | 0.42 | 0.35 | 0.33 | 0.79 | 6.29 | -0.28 | 78.55 | 0.35 | 4.20 | -0.15 | 10.26 | -0.11 | 0.70 | -0.52 | 0.98 |
| 24 | 1027 | 0.54 | 0.50 | 0.03 | 0.00 | 0.80 | 54.55 | 0.03 | 37.76 | 0.02 | 3.26 | 0.00 | 3.26 | 0.00 | 1.17 | 0.87 | 1.15 |
| 25 | 1028 | 0.92 | 0.27 | 0.30 | 0.39 | 0.79 | 4.43 | -0.21 | 93.47 | 0.30 | 0.70 | -0.04 | 0.47 | -0.08 | 0.93 | -1.95 | 0.99 |
| 26 | 1029 | 0.86 | 0.35 | 0.32 | 0.35 | 0.79 | 87.18 | 0.32 | 6.53 | -0.13 | 4.20 | -0.27 | 1.63 | -0.08 | 0.47 | -1.11 | 0.98 |
| 27 | 1030 | 0.53 | 0.50 | 0.32 | 0.25 | 0.79 | 53.61 | 0.32 | 32.40 | -0.11 | 6.06 | -0.30 | 7.23 | -0.09 | 0.70 | 0.89 | 0.99 |
| 28 | 1031 | 0.78 | 0.41 | 0.40 | 0.38 | 0.79 | 79.25 | 0.40 | 3.73 | -0.03 | 2.10 | -0.15 | 13.99 | -0.33 | 0.93 | -0.6 | 0.95 |
| 29 | 1055 | 0.29 | 0.46 | 0.37 | 0.28 | 0.79 | 29.84 | 0.37 | 1.17 | -0.08 | 11.89 | 0.00 | 56.18 | -0.28 | 0.93 | 1.78 | 0.98 |
| 30 | 1033 | 0.85 | 0.35 | 0.42 | 0.43 | 0.79 | 1.40 | -0.12 | 7.46 | -0.35 | 4.20 | -0.13 | 86.48 | 0.42 | 0.47 | -1.09 | 0.94 |
| 31 | 1062 | 0.89 | 0.31 | 0.17 | 0.25 | 0.79 | 1.63 | -0.21 | 2.80 | -0.02 | 4.43 | -0.04 | 90.44 | 0.17 | 0.70 | -1.39 | 1.02 |
| 32 | 1035 | 0.2 | 0.40 | 0.10 | 0.05 | 0.80 | 8.16 | 0.04 | 20.05 | 0.10 | 41.26 | 0.04 | 29.60 | -0.13 | 0.93 | 2.44 | 1.08 |
| 33 | 1036 | 0.44 | 0.50 | 0.27 | 0.20 | 0.80 | 32.87 | 0.01 | 13.75 | -0.23 | 44.99 | 0.27 | 6.76 | -0.23 | 1.63 | 1.18 | 1.02 |
| 34 | 1037 | 0.76 | 0.43 | 0.33 | 0.31 | 0.79 | 3.73 | -0.17 | 8.62 | -0.12 | 76.46 | 0.33 | 10.26 | -0.21 | 0.93 | -0.35 | 1.00 |
| 35 | 1001 | 0.35 | 0.48 | 0.27 | 0.19 | 0.80 | 46.15 | -0.15 | 35.43 | 0.27 | 4.43 | -0.04 | 12.82 | -0.12 | 1.17 | 1.78 | 1.00 |
| 36 | 1038 | 0.69 | 0.46 | 0.45 | 0.40 | 0.79 | 20.28 | -0.36 | 5.59 | -0.06 | 69.93 | 0.45 | 3.73 | -0.19 | 0.47 | -0.04 | 0.92 |
| 37 | 1039 | 0.36 | 0.48 | 0.18 | 0.11 | 0.80 | 51.98 | 0.02 | 36.36 | 0.18 | 2.80 | -0.19 | 8.16 | -0.18 | 0.70 | 1.57 | 1.08 |
| 38 | 1040 | 0.39 | 0.49 | 0.41 | 0.32 | 0.79 | 39.39 | -0.13 | 39.86 | 0.41 | 15.15 | -0.25 | 4.90 | -0.17 | 0.70 | 1.4 | 0.95 |
| 39 | 1041 | 0.26 | 0.44 | 0.15 | 0.09 | 0.80 | 56.18 | 0.00 | 13.29 | -0.10 | 3.73 | -0.11 | 26.11 | 0.15 | 0.70 | 2.23 | 1.08 |
| 40 | 1042 | 0.63 | 0.48 | 0.39 | 0.33 | 0.79 | 7.23 | -0.14 | 5.13 | -0.24 | 64.10 | 0.39 | 23.08 | -0.20 | 0.47 | 0.33 | 0.96 |
Test statistics from CTT and IRT analyses of the 40 item RANZCOG FSEP trial instrument
| Number of candidates, N | 877 | This was considered adequate for the purposes of a trial analysis for informing refinements to the extended test instrument. The resultant standard error of measurement for item difficulty parameter estimates was small at 0.07 logits. |
| Cronbach's Alpha | 0.80 | This was promising given the use of some underperforming items and a shortened test form. However, the intention will be to increase test length, item quality and test targeting to achieve a value in excess of 0.9. |
| Item Separation Reliability | 1.00 | This provides evidence that item parameter estimates are adequately separable and varied. |
| WLE Person Separation Reliability | 0.71 | Much as for Cronbach's Alpha, this value will need to be increased with the introduction of additional quality, targeted items. High Person Separation values are of particular importance when determining the number of performance levels and corresponding cut-scores that can be specified for a single assessment. |
| Mean Test Score (and Standard Deviation) | 26.7 (5.7) | These values (mean and standard deviation) suggest that the test is not too easy or too difficult for the practitioner population and is not subject to "floor" or "ceiling" effects. |
| Mean Item Infit (and Standard Deviation) | 1.00 (0.05) | These values (mean, and in particular, standard deviation) support the assumption that the FSEP instrument measures a single, unidimensional construct. This was important for justifying continued use of the Rasch-based methodology. |
| Proportion of t-tests outside 95% confidence interval | 7.75 (5.98 – 9.52) | This proportion indicates a slight departure from unidimensionality. Other item and test statistics did not detect this departure. This technique will be repeated once further item revisions have been carried out. Items with strong opposite loadings will be compared through qualitative review and evaluated against the intended construct. |
Figure 3Variable map from the initial assessment data.
Cognitive skills audit as carried out by the specialist panel
| Q20 ID1023 | -1.95 | Demonstrating a knowledge of fetal heart rate control |
| Q25 ID1028 | -1.91 | Demonstrating an understanding of the physiology of fetal heart rate control |
| Q4 ID1008 | -1.52 | Application of definition to interpret trace characteristic (baseline fetal heart rate) |
| Q31 ID1062 | -1.46 | Knowledge of definition of hyperstimulation (physiology of) as per local guidelines |
| Q17 ID1020 | -1.39 | Knowledge of the causes of reduced baseline variability |
| Q1 ID1002 | -1.22 | Combine basic trace and physiology information to determine appropriate management decision within clinical context |
| Q2 ID1006 | -1.22 | Knowledge of definition of the baseline range as per local guidelines |
| Q16 ID1019 | -1.19 | Knowledge of indications for EFM as per local guidelines |
| Q6 ID1003 | -1.16 | Knowledge and application of a definition (baseline variability) |
| Q21 ID1024 | -1.11 | Recognition of common abnormal trace pattern |
| Q26 ID1029 | -1.10 | Recognition of appropriate/inappropriate indications for EFM as per local guidelines |
| Q30 ID1033 | -1.09 | Combine basic trace and physiology information to determine appropriate management decision within clinical context |
| Q12 ID1015 | -0.60 | Interpretation of CTG trace abnormaility (receptors) |
| Q28 ID1031 | -0.55 | Synthesising trace and physiology information to determine appropriate management decision within clinical context |
| Q23 ID1026 | -0.52 | Knowledge of CTG trace limitations (sensitivity/specificity) |
| Q19 ID1022 | -0.40 | Knowledge of indications (or lack of indications) for EFM as per guidelines |
| Q34 ID1037 | -0.35 | Recognising appropriate management for the given circumstance |
| Q5 ID1009 | -0.22 | Demonstrating an understanding of the definition of baseline variability |
| Q22 ID1025 | -0.20 | Understanding the relative importance of CTG trace characteristics (baseline variability) |
| Q36 ID1038 | -0.16 | Identification of correctly paraphrased physiology definition (acceleration) |
| Q18 ID1021 | -0.05 | Synthesising trace and physiology information to determine appropriate management decision within clinical context |
| Q13 ID1016 | -0.04 | Understanding the relative importance of CTG trace characteristics (baseline variability) |
| Q11 ID1014 | 0.29 | Application of definition to interpret trace characteristic (baseline fetal heart rate) |
| Q8 ID1011 | 0.31 | Identification of correctly paraphrased physiology definition (CTG baseline fetal heart rate) |
| Q40 ID1042 | 0.33 | Recall of definitions of early decelerations |
| Q3 ID1007 | 0.44 | Application of definitions to trace characteristics (baseline fetal heart rate and baseline variability) |
| Q7 ID1010 | 0.55 | Synthesising trace and physiology information in relation to the fetal condition |
| Q10 ID1013 | 0.55 | Synthesising trace and physiology information to determine appropriate management decision within clinical context |
| Q14 ID1017 | 0.56 | Synthesising trace and physiology information to determine appropriate management decision within clinical context |
| Q27 ID1030 | 0.87 | Synthesising trace and physiology information in relation to the fetal condition |
| Q24 ID1027 | 0.89 | Synthesising trace and physiology information to determine fetal wellbeing within the clinical context |
| Q9 ID1012 | 1.06 | Synthesising trace and physiology information in relation to the fetal condition |
| Q33 ID1036 | 1.18 | Synthesising trace and physiology information to determine appropriate management decision within clinical context |
| Q15 ID1018 | 1.18 | Synthesising trace and physiology information to determine appropriate management decision within clinical context |
| Q37 ID1039 | 1.40 | Synthesising trace and physiology information to determine appropriate management decision within clinical context |
| Q38 ID1040 | 1.57 | Application of definition to interpret trace characteristic |
| Q29 ID1055 | 1.78 | Demonstrating a knowledge of the physiology of fetal heart rate control |
| Q35 ID1001 | 1.78 | Synthesising trace and physiology information to determine appropriate management decision within clinical context |
| Q39 ID1041 | 2.23 | Synthesising trace and physiology information to determine fetal wellbeing within the clinical context |
| Q32 ID1035 | 2.44 | Understanding the definition of the baseline fetal heart rate |
Figure 4Items ranked by relative difficulty with cognitive skill descriptions (preliminary item cluster cut-points shown as vertical dashed lines).
Empirically derived competency levels for the FSEP assessment variable
| To achieve correct responses at this level, participants need to be able to recognise what is normal in terms of the CTG. They also need to appreciate the physiology implicit in the normal FHR control. They need to know the definitions of the individual characteristics of a normal CTG. They need to appreciate the indications and contraindications for continuous electronic fetal monitoring (EFM). Participants need to be able to recognise low level abnormalities and the principals of conservative management. | |
| To achieve correct responses at level 2, in addition to the previous requirements, participants need to be able to recognise the uteroplacental and fetal physiology implicit in the more common CTG abnormalities. They need to be able to manage these abnormalities within a given context. They need to appreciate the limitations as well as the different modalities of EFM. They also need to recognise trends in CTGs and the implications of those trends. Some of the more basic skills from level 1 are linked to harder CTGs in these level 2 items. | |
| To achieve correct responses at level 3, participants need, in addition to the previous requirements, a detailed understanding and appreciation of the physiology of high risk as well as less common FHR abnormalities. Participants need to appreciate additional forms of fetal assessment and their applicability. At this level, practitioners also need to be able to recognise errors in information and interpretation. They need to be able to make high level management decisions based on accurate synthesis of complex information from a wide range of information sources. | |
Figure 5Draft blueprint for proposed 50 item test (additional content lists are available to item writers to elucidate each of the four column categories).